26-A-19195-ACC INCREMENTAL CARDIOVASCULAR BENEFITS OF GLP1 RECEPTOR AGONISTS IN PATIENTS WITH TYPE 2 DIABETES AND HEART FAILURE ON SGLT2 INHIBITORS UNDERGOING TRANSCATHETER AORTIC VALVE IMPLANTATION: A REAL-WORLD COHORT STUDY

View at publisher Summarise with VIRAT
Authors: Shawn Wang, Hoang Nhat Pham, Ramzi Ibrahim, Dwani D. Patel, Nathan Anthony Giauque, Ahmed Mahmoud, Enkhtsogt Sainbayar, Mahmoud Hassan Abdelnabi, Amitoj Singh, Dan Sorajja, Kwan Seung S Lee, Reza Arsanjani
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Cardiac Valve Diseases and Treatments Diabetes Treatment and Management Heart Failure Treatment and Management

Publication details

Journal / source
Journal of the American College of Cardiology
Volume
87
Issue
13
Pages
A1014–A1014
Publication date
27 March 2026
Language
EN